A growing number of hospitals are investigating antibody testing and blood plasma therapy as a way to combat the new coronavirus in sick patients. WSJ’s Daniela Hernandez explains. Photo illustration: ...
The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and ...
Tasso has received $17 million in new funding to scale up production of its self-administered blood collection devices, designed to help enable telemedicine and diagnostic testing from the home. The ...
Vitestro secures $70M Series B funding to expand its autonomous robotic blood collection technology and global healthcare adoption.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results